Renal Cancer - Results from #960

Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing. May 2, 2023

Extensive intratumor regional epigenetic heterogeneity in clear cell renal cell carcinoma targets kidney enhancers and is associated with poor outcome. May 1, 2023

Long term experience of robotic retroperitoneal partial nephrectomy as the default approach in the management of renal masses: should the paradigm shift? May 1, 2023

How to manage renal masses in kidney transplant recipients? A collaborative review by the EAU-YAU kidney transplantation and renal cancer working groups. April 28, 2023

Evaluation of Growth Rates for Small Renal Masses in Elderly Patients Undergoing Active Surveillance. April 28, 2023

Radiogenomic associations clear cell renal cell carcinoma: an exploratory study. April 27, 2023

Point of care parenchymal volume analyses to estimate split renal function and predict functional outcomes after radical nephrectomy. April 27, 2023

Comparison between minimally-invasive partial nephrectomy and open partial nephrectomy for complex renal tumors: A systematic review and meta-analysis. April 26, 2023

Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma. April 26, 2023

Impact of Therapy Management on Axitinib-Related Adverse Events in Patients With Advanced Renal Cell Carcinoma Receiving First-Line Axitinib + Checkpoint Inhibitor. April 25, 2023

Identification and verification of prognostic cancer subtype based on multi-omics analysis for kidney renal papillary cell carcinoma. April 25, 2023

Tumor and immune remodeling following radiotherapy in human renal cell carcinoma. April 24, 2023

Clear cell renal cell carcinoma molecular variations in non-Hispanic White and Hispanic patients. April 24, 2023

Volumetric Quantitative Contrast-enhanced Ultrasonography Evaluation of Complex Renal Cysts: An Adjunctive Metric to the Bosniak Classification System to Predict Malignancy. April 24, 2023

Expression of RSUME is Associated With Poor Prognosis in Clear Cell Renal Carcinoma: Involvement of ROS Related Metabolism. April 21, 2023

Predicting the recurrence risk of renal cell carcinoma after nephrectomy: potential role of CT-radiomics for adjuvant treatment decisions. April 21, 2023

Update on combined immunotherapy for the treatment of advanced renal cell carcinoma. April 20, 2023

Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification. April 20, 2023

PIK3C2A is a prognostic biomarker that is linked to immune infiltrates in kidney renal clear cell carcinoma. April 20, 2023

Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC). April 19, 2023

Page 49 of 456